Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
The American Journal of Managed Care|April 18, 2014
Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in MedicaidSeth A Seabury, Dana P Goldman, Iftekhar Kalsekar, et al.
Journal of Comparative Effectiveness Research|November 21, 2023
Real-world assessment of treatment inertia in the management of patients treated for major depressive disorder in the USAJohn J Sheehan, Chris LaVallee, Keshia Maughn, et al.
Psychiatric Research and Clinical Practice|September 14, 2022
Economic Burden of Treatment-Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United StatesJay Lin, Holly Szukis, John J Sheehan, et al.
Journal of Medical Economics|July 21, 2015
Cardiovascular event costs in patients with Type 2 diabetes mellitusStephen S Johnston, John J Sheehan, Manan Shah, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 19, 2016
Incremental increases in economic burden parallels cardiometabolic risk factors in the USR Brett McQueen, Vahram Ghushchyan, Temitope Olufade, et al.
Advances in Therapy|January 4, 2016
Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 InhibitorsAmanda M Farr, John J Sheehan, Matthew Brouillette, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 2, 2017
Value-Based Payments and Incentives to Improve Care: A Case Study of Patients with Type 2 Diabetes in Medicare AdvantageJesse Sussell, Kata Bognar, Taylor T Schwartz, et al.
Clinical Pharmacology : Advances and Applications|August 14, 2012
Management of antipsychotic treatment discontinuation and interruptions using model-based simulationsMahesh N Samtani, John J Sheehan, Dong-Jing Fu, et al.
Pageof 9